Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 647-653

  Rasheed, J K ^a   Jay, C ^b   Metchock, B ^c   Berkowitz, F ^c   Weigel, L ^a   Crellin, J ^d   Steward, C ^a   Hill, B ^c   Medeiros, A A ^d   Tenover, F C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BIOMÉRIEUX   (France)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; MONOBACTAM; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; APLASTIC ANEMIA; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATION; CASE REPORT; CONTROLLED STUDY; DOT HYBRIDIZATION; ESCHERICHIA COLI; FEMALE; HUMAN; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 18144432455     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.647     Document Type: Article

References (54)

1. Ambler, R. P., A. F. W. Coulson, J.-M. Frere, J.-M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-272.
2. Arlet, G., M. Rouveau, D. Bengoufa, M. H. Nicolas, and A. Philippon. 1991. Novel transferable extended-spectrum β-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime. FEMS Microbiol. Lett. 81:57-62.
3. Bakken, J. S., C. C. Sanders, and K. S. Thomson. 1987. Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein. J. Infect. Dis. 155:1220-1225.
4. Barthélémy, M., J. Peduzzi, and R. Labia. 1988. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-1). Biochem. J. 251:73-79.
5. Barthélémy, M., J. Peduzzi, H. B. Yaghlane, and R. Labia. 1988. Single amino acid substitution between SHV-1 β-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme. FEBS Lett. 231:217-220.
6. Billot-Klein, D., L. Gutmann, and E. Collatz. 1990. Nucleotide sequence of the SHV-5 β-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:2439-2441.
7. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
8. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolated from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
9. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
10. Farmer, J. J., III, and M. T. Kelly. 1991. Enterobacteriaceae, p. 360-383. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
11. Garbarg-Chenon, A., V. Godard, R. Labia, and J.-C. Nicolas. 1990. Nucleotide sequence of SHV-2 β-lactamase gene. Antimicrob. Agents Chemother. 34:1444-1446.
12. Gootz, T. D., F. C. Tenover, S. A. Young, K. P. Gordon, and J. J. Plorde. 1985. Comparison of three DNA hybridization methods for the detection of the aminoglvcoside 2″-O-adenylyltransferase gene in clinical bacterial isolates Antimicrob. Agents Chemother. 28:69-73.
13. Gouby, A., C. Neuwirth, G. Bourg, N. Bouziges, M. J. Carles-Nurit, E. Despaux, and M. Ramiz. 1994. Epidemiologic study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J. Clin. Microbiol. 32:301-305.
14. Harder, K. J., H. Nikaido, and M. Matsuhashi. 1981. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob. Agents Chemother. 20:549-552.
15. Herzberg, O., G. Kapadia, B. Blanco, T. S. Smith, and A. Coulson. 1991. Structural basis for the inactivation of the P54 mutant of β-lactamase from Staphylococcus aureus PC1. Biochemistry 30:9503-9509.
16. Hiraoka, M., R. Okamoto, M. Inoue, and S. Mitsuhashi. 1989. Effects of β-lactamases and omp mutations on susceptibility to β-lactam antibiotics in Escherichia coli. Antimicrob. Agents Chemother. 33:382-386.
17. Huletsky, A., F. Couture, and R. C. Levesque. 1990. Nucleotide sequence and phylogeny of SHV-2 β-lactamase. Antimicrob. Agents Chemother. 34:1725-1732.
18. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.
19. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J. Clin. Microbiol. 32:691-696.
20. Killgore, G. E., and H. Kato. 1994. Use of arbitrary primer PCR to type Clostridium difficile and comparison of results with those by immunoblot typing. J. Clin. Microbiol. 32:1591-1593.
21. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob Agents Chemother. 39:2593-2601.
22. Mabilat, C., and P. Courvalin. 1990. Development of "oligotyping" for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 34:2210-2216.
23. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum β-lactamases, p. 553-559. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.) Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
24. Mariotte, S., P. Nordmann, and M. H. Nicolas. 1994. Extended-spectrum β-lactamase in Proteus mirabilis. J. Antimicrob. Chemother. 33:925-935.
25. Maslow, J. N., M. E. Mulligan, and R. D. Arbeit. 1994. Recurrent Escherichia coli bacteremia. J. Clin. Microbiol. 32:710-714.
26. Maslow, J. N., A. M. Slutky, and R. D. Arbeit. 1993. Application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-571. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
27. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
28. Medeiros, A. A. 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24:S19-S45.
29. Medeiros, A. A., T. F. O'Brien, E. Y. Rosenberg, and H. Nikaido. 1987. Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J. Infect. Dis. 156:751-757.
30. Mercier, J., and R. C. Levesque. 1990. Cloning of SHV-2, OHIO-1, and OXA-6 β-lactamases and cloning and sequencing of SHV-1 β-lactamase. Antimicrob. Agents Chemother. 34:1577-1583.
31. Meyer, K. H., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Rahal. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann. Intern. Med. 119:353-358.
32. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed., vol. 13, no. 25. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
33. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards. Villanova, Pa.
34. Nicolas, M.-H., V. Jarlier, N. Honore, A. Philippon, and S. T. Cole. 1989. Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 33:2096-2100.
35. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
36. Palzkill, T., and D. Botstein. 1992. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 β-lactamase. J. Bacteriol. 174: 5237-5243.
37. Pangon, B., C. Bizet, A. Buré, F. Pinchon, A. Philippon, B. Regnier, and L. Gutmann. 1989. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase. J. Infect. Dis. 159:1005-1006.
38. Peduzzi, J., M. Barthelemy, K. Tiwari, D. Mattioni, and R. Labia. 1989. Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 β-lactamase. Antimicrob. Agents Chemother. 33:2160-2163.
39. Petit, A., H. B. Yaghiane-Bouslama, L. Sofer, and R. Labia. 1992. Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae? FEMS Microbiol. Lett. 92:89-94.
40. Petrosino, J. F., and T. Palzkill. 1996. Systematic mutagenesis of the active site omega loop of TEM-1 β-lactamase. J. Bacteriol. 178:1821-1828.
41. Philippon, A., G. Arlet, and P. H. Lagrange. 1994. Origin and impact of plasmid-mediated extended spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1):17-29.
42. Philippon, A., R. Labia, and G. Jacoby. 1989. Extended spectrum β-lactamases. Antimicrob. Agents Chemother. 33:1131-1136.
43. SHV-2) of Klebsiella ozaenae. Nucleic Acids Res. 18:4916.
44. Podbielski, A., J. Schonling, B. Melzer, K. Warnatz, and H.-G. Leusch. 1991. Molecular characterization of a new plasmid-encoded SHV-type β-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J. Gen. Microbiol. 137:569-578.
45. Portnoy, D. A., S. L. Moseley, and S. Falkow. 1981. Characterization of plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 31:775-782.
46. Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193-2199.
47. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed., p. 9.31-9.62. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
48. Sirot, J., C. Chanal, A. Petit, D. Sirot, R. Labia, and G. Gerbaud. 1988. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third generation cephalosporins: epidemiologic studies. Rev. Infect. Dis. 10:850-859.
49. Sougakoff, W., S. Goussard, G. Gerbaud, and P. Courvalin. 1988. Plasmid-mediated resistance to third generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Rev. Infect. Dis. 10:879-884.
50. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
51. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
52. Tenover, F. C., M. B. Huang, J. K. Rasheed, and D. H. Persing. 1994. Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. J. Clin. Microbiol. 32:2729-2737.
53. Vakulenko, S. B., M. Toth, P. Taibi, S. Mobashery, and S. A. Lerner. 1995. Effects of Asp-179 mutations in TEMpUC19 β-lactamase on susceptibility to β-lactams. Antimicrob. Agents Chemother. 39:1878-1880.
54. Weber, D. A., C. C. Sanders, J. S. Bakken, and J. P. Quinn. 1990. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli. J. Infect. Dis. 162:460-465.